French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.

French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net profit by 1.9...

French pharmaceutical giant Sanofi-Aventis said Friday higher sales of its most widely prescribed treatments helped lift its core earnings in the third quarter.

French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities...

Sanofi-Aventis named former GlaxoSmithKline executive Chris Viehbacher as new chief executive in a move aimed at redefining its strategy, the French drugmaker said...

Sanofi-Aventis SA expects to make 31 submissions for new drugs by the end of 2010, the world’s third largest drugmaker announced Monday.In its first such update...